← Leaderboards
Zhengxin Cai
Yale University
$10,214,567
Attributed
$12,717,189
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,717,189 · 10
By mechanism
R01$8,402,078 · 4
RF1$2,503,003 · 1
R21$891,310 · 2
R41$499,844 · 1
R03$250,325 · 1
K01$170,629 · 1
Top collaborators
- Evelyn Mr Lake2 shared
- Stephen M Strittmatter2 shared
- Takuya Toyonaga2 shared
Most similar at Yale University
Same institution · by research overlap
- Elias Lolis$7,866,115
- Timothy Newhouse$3,085,797
- Jane R. Taylor$21,569,015
- William Jorgensen$15,848,158
- Jeffrey R. Bender$22,395,373
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposS DiseaseTracerPositron-Emission TomographyBrainBindingDensityLeadClinical TrialsIn VitroAffinityLigandsTranslatingImageSpecificityIn VivoSynapsesPublic Health RelevanceRadiotracerImmunohistochemistryRadiolabeledImaging ProbeBaseLabel
Grant awards (20)
Multimodal imaging of prodromal synaptic, circuit, and network-level dysfunction in a murine model of Alzheimer's disease$833,826
R01 · FY2025 · NS
SV2A PET in Spinal Cord Injury Imaging$664,037
R01 · FY2025 · NS · contact PI
Scalable cGMP production of SV2A PET tracers using photoredox chemistry for applications in clinical trials and early AD diagnosis$499,844
R41 · FY2025 · AG · contact PI
SV2A PET in Spinal Cord Injury Imaging$653,501
R01 · FY2024 · NS · contact PI
Development of PET imaging probes for ROCK2$809,732
R01 · FY2023 · AG · contact PI
SV2A PET in Spinal Cord Injury Imaging$683,356
R01 · FY2023 · NS · contact PI
Multimodal imaging of prodromal synaptic, circuit, and network-level dysfunction in a murine model of Alzheimer's disease$2,503,003
RF1 · FY2022 · NS
Development of PET imaging probes for ROCK2$826,482
R01 · FY2022 · AG · contact PI
SV2A PET in Spinal Cord Injury Imaging$687,529
R01 · FY2022 · NS · contact PI
Development of PET imaging probes for ROCK2$836,532
R01 · FY2021 · AG · contact PI
Brain Penetrant PARP Targeted PET Imaging Probes$83,750
R03 · FY2021 · CA · contact PI
Brain Penetrant PARP Targeted PET Imaging Probes$82,825
R03 · FY2021 · CA · contact PI
Development of Novel SV2A PET Agents for Early Detection of Alzheimers Disease$811,697
R01 · FY2020 · AG · contact PI
Development of novel CXCR5 PET Imaging probe for Angioimmunoblastic T-cell Lymphoma$430,685
R21 · FY2020 · CA · contact PI
Development of BBB Permeable PD-L1 PET Imaging Agents$209,375
R21 · FY2020 · EB · contact PI
Brain Penetrant PARP Targeted PET Imaging Probes$83,750
R03 · FY2020 · CA · contact PI
Development of Novel SV2A PET Agents for Early Detection of Alzheimers Disease$800,508
R01 · FY2019 · AG · contact PI
Development of BBB Permeable PD-L1 PET Imaging Agents$251,250
R21 · FY2019 · EB · contact PI
Development of Novel SV2A PET Agents for Early Detection of Alzheimers Disease$794,878
R01 · FY2018 · AG · contact PI
Synthesis and Evaluation of an 18F Labeled SV2A Ligand as a Novel Biomarker for Alzheimers Disease$170,629
K01 · FY2017 · EB · contact PI